tetrahydro-11-deoxycortisol has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Discafani, CM; Downs, EC; Hailey, JA; Plunkett, ML; Popper, TL; Robertson, NE; Runkle, RL; Sarre, O | 1 |
| Casey, R; Folkman, J; Gonzalez, EM; Li, WW | 1 |
2 other study(ies) available for tetrahydro-11-deoxycortisol and Disease Models, Animal
| Article | Year |
|---|---|
A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis.
Topics: Animals; Cortodoxone; Disease Models, Animal; Drug Synergism; Female; Heparin; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Protamines | 1991 |
Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
Topics: Administration, Topical; Angiogenesis Inducing Agents; Animals; beta-Cyclodextrins; Betamethasone; Corneal Neovascularization; Cortodoxone; Cyclodextrins; Disease Models, Animal; Drug Synergism; Hydrocortisone; Male; Rabbits | 1991 |